Facts
The French Rugby League (Fédération Française de Rugby à XIII, FFR XIII) charges respondent M02 for a violation of the Anti-Doping Rules. Respondent provided a sample for doping control purposes during a match on October 30, 2004. Analysis of the sample highlighted the presence of salbutamol which is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.
History
The respondent had used a pharmaceutical product to treat his asthma. He has a cetificate for the use from his pulmonogolist.
The panel considers the use of two doses for treating a sudden asthma attack as legitimate. But the respondent failed to provide a medical justification for this.
Decision
1. The sanction: a period of ineligibility of nine months, as pronounced in the decision by the disciplinary committee of the FFR XIII, is upheld but extended to all French sport federations.
2. The decision starts on the date of notification.
3. The decision will be published and sent to the parties involved.
